To identify the biological processes that are specific to MYCN-amplified NB when compared to non-MYCN-amplified NB, we analyzed gene expression data derived from 39 commonly used human NB cell lines, as described by Harneza et al. [40], and we identified 2738 differentially regulated genes (FDR ≤ 0.05) in MYCN-amplified vs. non-MYCN-amplified NB (Table S1). This evidence concerns the gene MYCN and neuroblastoma.